Advent Life Sciences Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 6

- Investments
- 73
- Portfolio
- 23
- Exits
- 37

Advent Life Sciences General Information
Description
Founded in 2009, Advent Life Sciences is a venture capital firm based in London, England. The firm seeks to invest in early and mid-stage life sciences firms. The firm focuses on new drug discovery, small molecules, biologics and new modalities, med tech, enabling technologies and vaccines.
Contact Information
- 158-160 North Gower Street
- London NW1 2ND
- England, United Kingdom
Advent Life Sciences Investments (73)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Highlight Therapeutics | 05-Feb-2021 | Later Stage VC | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | |
000000 00000000000 | 13-Oct-2020 | 00000 00000 | 000.00 | Drug Discovery | Product Development | 000000 000000 00.0 |
000 | 12-Aug-2020 | 00000 00000 | 000.00 | Biotechnology | Clinical Trials - Phase 2 | 000000 0000000 |
00000 000000000000 | 31-Jul-2020 | 00000 00000 | 00.000 | Drug Discovery | Generating Revenue | |
000000 00000000000 | 09-Apr-2020 | 00000 00000 | 00.00 | Drug Discovery | Generating Revenue | 000000 000000 00.0 |
00000000 000000000 | 07-Apr-2020 | 00000 00000 | 00.000 | Drug Discovery | Generating Revenue | 000000 000000 00.0 |
000 000000000000 | 02-Apr-2020 | 0000 00000 | 000.00 | Drug Discovery | Generating Revenue | 0000 00000 00.0 |
00000 000000000000 | 18-Feb-2020 | 0000 00000 | 00.000 | Drug Discovery | Startup | |
MiroBio | 07-Oct-2019 | Early Stage VC | 000.00 | Biotechnology | Startup | 0000000 00000 00 |
Acutus Medical | 20-Jun-2019 | Later Stage VC | 00000 | Diagnostic Equipment | Generating Revenue/Not Profitable | 0000000 00000 00 |
Advent Life Sciences Exits (37)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Tridek-One | 11-Jan-2021 | Out of Business | |
000000 00000000000 | 26-Oct-2020 | 000000 0000000000 | 000.00 |
00000 000000000000 | 09-Sep-2020 | 000000000000000000 | 00000 |
000000 0000000 | 06-Aug-2020 | 000 | 00000 |
0000000 0000000000 | 01-Jan-2020 | 000 00 00000000 | |
00000000 | 01-Jul-2019 | 000 00 00000000 | |
0000000 0000000000 | 31-Oct-2018 | 000 | 00000 |
000000 00000000000 | 25-May-2018 | 000 | 0000 |
TandemLife | 04-Apr-2018 | Merger/Acquisition | 00000 |
Aravive Inc | 30-Jun-2017 | Secondary Transaction - Open Market |
Advent Life Sciences Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
This information is available in the PitchBook Platform. To explore Advent Life Sciences‘s full profile, request access.
Request a free trialAdvent Life Sciences Investments by Industry, Year, and Region
Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialAdvent Life Sciences Team (20)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Kaasim Mahmood | General Partner | 0 | 0 | 0 | London, United Kingdom |
Rajesh Parekh Ph.D | General Partner | 00 | 0 | 00 | London, United Kingdom |
Shahzad Malik MD | General Partner | 00 | 0 | 0 | London, United Kingdom |
Donald Drakeman Ph.D | Venture Partner | London, United Kingdom | |||
Karen LaRochelle | Venture Partner | London, United Kingdom |
Advent Life Sciences Co-Investors (77)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Novo Holdings | 3 | 0 |
![]() |
![]() |
|
OrbiMed | 0 | 0 | 0 |
![]() |
![]() |
Canaan Partners | 0 | 0 |
![]() |
![]() |
|
FORBION | 0 | 0 | 0 |
![]() |
![]() |
New Enterprise Associates | 0 | 0 |
![]() |
![]() |